Sales and Marketing

Showing 15 posts of 11524 posts found.

Avastin’s new licence ‘more cost-effective’

January 30, 2008 Sales and Marketing

Avastin has won a broader European licence for metastatic colorectal cancer, a move manufacturer Roche believes will make it more …

Novartis’ European chief says ‘Geotailoring’ will speed decision making and bring it closer to customers

January 28, 2008 Sales and Marketing Eric Cornut, Novartis

Q: Europe’s biggest market Germany is preparing for some major reforms at the moment. How is Novartis responding to that …

Jimenez aims for savings and marketing rejuvenation

January 28, 2008 Sales and Marketing Jimenez, Jiminez, Novartis

The head of Novartis’ pharmaceutical business Joe Jimenez has set out his plans to make the division more efficient and …

Pfizer sales dip during year of restructuring

January 25, 2008 Sales and Marketing generics

Pfizer’s pharmaceutical sales fell slightly last year, hit by patent expiries and difficult market conditions for its leading drug Lipitor. …

Avandia hit by further restrictions

January 25, 2008 Sales and Marketing reg, safety

GlaxoSmithKline has strengthened the safety warnings on its diabetes drug Avandia following recommendations from European regulators. The drug was hit …

Avastin launched in UK for kidney cancer

January 25, 2008 Sales and Marketing avastin, rcc

Avastin has been launched in the UK as a first-line treatment for renal cell carcinoma (RCC) to be used in …

NICE contributes to government’s anti-obesity vision

January 24, 2008 Sales and Marketing hc

The rise of obesity in Britain could be halted if exercise were built into individual daily routines, according to new …

Genmab’s MabThera rival enters phase III

January 24, 2008 Sales and Marketing

Genmab and GSK's new biotech drug HuMax has entered phase III trials for use in rheumatoid arthritis, the first of …

Pharma companies raided over alleged generic blocking

January 18, 2008 Sales and Marketing

Pharmaceutical companies across Europe have been raided by EU investigators who suspect illegal moves to block the launch of cheaper …

Pharmafocus: A Year in Review

January 17, 2008 Research and Development, Sales and Marketing 2007, biotech, pharma, year in review

 A look back at some of the biggest stories to affect the UK pharmaceutical industry in 2007, including a string …

US problems hit Novartis

January 17, 2008 Sales and Marketing generics

The entry of three generic competitors and the withdrawal of irritable bowel drug Zelnorm wiped billions off Novartis' revenues in …

MPs call for more generic prescribing

January 17, 2008 Sales and Marketing

Pharmaceutical marketing and the NHS drugs bill are once again in the spotlight with MPs criticising the industry's influence and …

European research service to track technology adoption by physicians

January 17, 2008 Sales and Marketing

US market research company Manhattan Research has launched a new European service to examine trends in physician's use of technology …

GSK’s allergy treatment Avamys approved in Europe

January 17, 2008 Sales and Marketing

European regulators have approved GlaxoSmithKline's new once-daily corticosteroid nasal spray for allergic rhinitis. Avamys was granted a licence to treat …

Genentech growth to slow in 2008

January 15, 2008 Sales and Marketing

The spectacular growth which has made Genentech the world's biggest biotech company is set to slow in 2008, as its …
The Gateway to Local Adoption Series

Latest content